Vera Therapeutics, Inc.

8-K Director or officer change Jul 9, 2026 8-K Other events Jul 7, 2026 8-K Other events Jun 2, 2026 8-K Shareholder vote results May 26, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 8-K Director or officer change Dec 18, 2025 8-K Other events Dec 10, 2025 8-K Director or officer change Nov 26, 2025 8-K Other events Nov 6, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Entered a material agreement; Terminated a material agreement Aug 5, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Jun 3, 2025 8-K Regulation FD disclosure; Other events Jun 2, 2025 8-K Shareholder vote results May 19, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 7, 2024 8-K Other events Oct 31, 2024 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Oct 28, 2024 8-K Regulation FD disclosure Oct 2, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Director or officer change Jul 2, 2024 8-K Director or officer change Jun 12, 2024 8-K Shareholder vote results May 17, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 9, 2024 10-K Fiscal year ended 2023-12-31 Mar 27, 2024 8-K Results of operations (earnings release) Mar 20, 2024